Ignite Creation Date:
2024-05-06 @ 3:24 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04620590
Status:
UNKNOWN
Last Update Posted:
2021-09-08
First Post:
2020-11-03
Brief Title:
An Open Label Phase IV Study to Evaluate Dapagliflozin Treatment in Type 2 Diabetes Mellitus Patients With Impaired Renal Function
Sponsor:
George Clinical Pty Ltd
Organization:
George Clinical Pty Ltd
Organization Data
Organization:
George Clinical Pty Ltd
Class:
INDUSTRY
Study ID:
UMCG 20-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
George Clinical Pty Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Ground Zero Pharmaceuticals | INDUSTRY |
| University Medical Center Groningen | OTHER |